PubMed Health⌕ Search

Biomedical subjects

B Peyton

Publications and source records attributed to B Peyton.

4 recordsLinked to original sources

Artificial aging of phenanthrene in porous silicas using supercritical carbon dioxide.

Expedited artificial aging is described and demonstrated using a novel system that circulates a solution of supercritical carbon dioxide and a hydrophobic organic sorbate (phenanthrene) through a closed loop containing a porous substrate. Unlike traditional methods used to simulate the natural aging process, our approach allows for real-time monitoring of sorption equilibria, and the process is highly accelerated due to the unique physical properties of supercritcal carbon dioxide. The effectiveness of the system to simulate aging was demonstrated with a series of experiments in which three silicas with varying particle and pore sizes were loaded with phenanthrene. Batch aqueous desorption experiments were used to evaluate the extent of the aging process. For the two types of particles containing the largest pores (i.e., mean diameters of 202 and 66 A), 95% and 86%, respectively, of the phenanthrene was released to the aqueous fraction within 3 h. In contrast, only 16% of the phenanthrene was released from particles having a mean pore diameter of 21 A after 24 h. These results were confirmed by the results from an aqueous column desorption experiment. Confounding factors that might contribute to slow aqueous desorption such as the hydration state of the particles' surfaces, the chemical form of the loaded phenanthrene, and the organic carbon content were investigated and/or normalized for all three particle types. Consequently, we were able to attribute the slow desorption behavior and the presence of the resistant fraction in the 21 A silica to pore effects. With properly designed experiments, the results of this study suggest that the supercritical fluid system could be extended to the study of contaminant aging and bioavailability in natural soils and sediments.

Adsorption↗

Oral pharmacokinetics of omeprazole and lansoprazole after single and repeated doses as intact capsules or as suspensions in sodium bicarbonate.

BACKGROUND: Omeprazole and lansoprazole can be given in sodium bicarbonate as, respectively, simplified omeprazole suspension and simplified lansoprazole suspension. We previously found the antisecretory effect of omeprazole 20 mg given as simplified omeprazole suspension to be lower than with intact capsules. However, lansoprazole 30 mg as simplified lansoprazole suspension produced an effect similar to that seen with intact capsules. AIM: To evaluate the absorption of both drugs when given orally as capsules or as suspensions in sodium bicarbonate. METHODS: In random order, we gave 5-day courses of omeprazole 20 mg and lansoprazole 30 mg as capsules and as suspensions in sodium bicarbonate to 12 healthy women. Serial blood samples were taken on days 1 and 5 of each course for pharmacokinetic measurements. RESULTS: There was impairment of omeprazole absorption when given as simplified omeprazole suspension. Maximum plasma concentration and area under the concentration/time curve were lower with simplified omeprazole suspension than with omeprazole capsules (P=0.034 and 0.013, respectively, on day 5). No differences were found in lansoprazole absorption when simplified lansoprazole suspension was compared with its standard capsule formulation. Relative bioavailability of omeprazole from simplified omeprazole suspension compared to the capsule was 58.4% on day 5. The corresponding value for lansoprazole was 84.7%. CONCLUSIONS: Simplified omeprazole suspension 20 mg does not supply adequate omeprazole for systemic absorption. Lansoprazole absorption from simplified lansoprazole suspension is maintained.

2-Pyridinylmethylsulfinylbenzimidazoles↗